clinical trial · NCT06569056
A Trial of HRS-8427 in the Treatment of Adults With Complicated Urinary Tract Infection, Including Acute Pyelonephritis
Jiangsu HengRui Medicine Co., Ltd.·phase3·recruiting·n = 578
Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP)HRS-8427Imipenem and Cilastatin SodiumHRS-8427 placeboImipenem and Cilastatin Sodium placebo
brief summary
The purpose of this study is to evaluate the efficacy and safety of HRS-8427 in patients with complicated urinary tract infection, including acute pyelonephritis.
started
Sep 25, 2024
primary completion
Nov 1, 2025
completion
Nov 1, 2025
last updated
Jan 22, 2025
official title
A Multi-center, Randomized, Double-blind, Active Controlled, Parallel Groups, Phase III Study to Evaluate the Efficacy and Safety of HRS-8427 in the Treatment of Adults With Complicated Urinary Tract Infection, Including Acute Pyelonephritis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol